{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:22:22Z","timestamp":1791490942571,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.05.055","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T08:05:13Z","timestamp":1654675513000},"page":"4922-4928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Characteristics and incidence of vaccine adverse events after Bacille Calmette\u2013Gu\u00e9rin vaccination: A national surveillance study in Japan from 2013 to 2017"],"prefix":"10.1016","volume":"40","author":[{"given":"Hideo","family":"Okuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishiro","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka-Taya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2022.05.055_b0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7883\/yoken.JJID.2018.446","article-title":"Study on the procedure for lot release of vaccines in Japan","volume":"72","author":"Kato","year":"2019","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.055_b0010","unstructured":"Ministry of Health, Labour and Welfare. Regulation for the enforcement of the immunization act."},{"key":"10.1016\/j.vaccine.2022.05.055_b0015","unstructured":"Ministry of Health, Labour and Welfare. Regulation for enforcement of the act on securing quality, efficacy, and safety of products, including pharmaceuticals and medical devices."},{"key":"10.1016\/j.vaccine.2022.05.055_b0020","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"key":"10.1016\/j.vaccine.2022.05.055_b0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7883\/yoken.JJID.2007.331","article-title":"Historical review of BCG vaccine in Japan","volume":"60","author":"Yamamoto","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.055_b0030","unstructured":"Ministry of Health, Labour and Welfare. The number of people who received the routine immunization. http:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html [accessed 17 January 2018]."},{"key":"10.1016\/j.vaccine.2022.05.055_b0035","unstructured":"Ministry of Health, Labour and Welfare. A post-vaccination survey on the health state of vaccines, April 2013\u2013March 2014, http:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000126452.pdf [accessed 17 January 2018]."},{"key":"10.1016\/j.vaccine.2022.05.055_b0040","unstructured":"Ministry of Health, Labour and Welfare, Ministry of Education. Ethical guidelines for epidemiological research, http:\/\/www.mhlw.go.jp\/general\/seido\/kousei\/i-kenkyu\/ekigaku\/0504sisin.html [accessed 17 January 2018]."},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.055_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the vaccine adverse event reporting system","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.05.055_b0050","doi-asserted-by":"crossref","first-page":"E470","DOI":"10.33321\/cdi.2016.40.52","article-title":"Adverse events following immunisation with Bacille Calmette-Guerin vaccination: Baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine","volume":"40","author":"Hendry","year":"2016","journal-title":"Commun Dis Intell Q Rep"},{"issue":"36","key":"10.1016\/j.vaccine.2022.05.055_b0055","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.055_b0060","series-title":"Plotkin's Vaccines","first-page":"1095","article-title":"Tuberculosis vaccines","author":"Hanekom","year":"2017"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.055_b0065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/172.2.574","article-title":"Osteitis caused by Bacille Calmette-Guerin vaccination: A retrospective analysis of 222 cases","volume":"172","author":"Kroger","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.055_b0070","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: A review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.055_b0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3201\/eid2103.140789","article-title":"Mycobacterium bovis BCG-associated osteomyelitis\/osteitis","volume":"21","author":"Chiu","year":"2015","journal-title":"Taiwan Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.055_b0080","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3201\/eid1509.081336","article-title":"Tokyo-172 BCG vaccination complications","volume":"15","author":"Jou","year":"2009","journal-title":"Taiwan Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.055_b0085","unstructured":"Taiwan Centers for Disease Control. Beginning January 1, 2016, revised routine childhood immunization schedule to designate Bacille Calmette-Gu\u00e9rin (BCG) vaccine for infants reaching 5 months of age and recommend BCG vaccine for infants at 5\u20138 months of age. https:\/\/www.cdc.gov.tw\/En\/Bulletin\/Detail\/n644Hq_KeoZcYlfzHGxmcQ?typeid=158 [accessed 17 January 2018]."},{"key":"10.1016\/j.vaccine.2022.05.055_b0090","first-page":"125","article-title":"Osteitis as a complication of BCG vaccination","volume":"84","author":"Koyama","year":"2009","journal-title":"Kekkaku"},{"key":"10.1016\/j.vaccine.2022.05.055_b0095","unstructured":"Takamatsu I, Tokunaga O. Frequency of BCG osteitis and future prospects in Japan. Health, Labour and Welfare Sciences Research Grants, Research on emerging and re-emerging infectious diseases and immunization in project report (in Japanese). 2010:106\u201310. https:\/\/mhlw-grants.niph.go.jp\/project\/18740."},{"key":"10.1016\/j.vaccine.2022.05.055_b0100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.inf.0000164769.22033.2c","article-title":"Serious adverse events associated with Bacille Calmette-Guerin vaccine in Canada","volume":"24","author":"Deeks","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.05.055_b0105","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1016\/j.vaccine.2018.05.098","article-title":"Clinical features and outcomes of Bacille Calmette-Guerin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization","volume":"36","author":"Rermruay","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.055_b0110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/adc.2005.078972","article-title":"Complications associated with the Bacille Calmette-Guerin vaccination in Ireland","volume":"91","author":"Bolger","year":"2006","journal-title":"Arch Dis Child"},{"issue":"20","key":"10.1016\/j.vaccine.2022.05.055_b0115","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.vaccine.2004.07.052","article-title":"BCG vaccine-associated suppurative lymphadenitis","volume":"23","author":"Teo","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.055_b0120","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1016\/j.vaccine.2014.08.032","article-title":"Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI((R)) in Singapore","volume":"32","author":"Soh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.055_b0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/pds.3383","article-title":"Complications of BCG vaccine SSI(R) recent story and risk management plan: The French experience","volume":"22","author":"Chol","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2022.05.055_b0130","first-page":"47","article-title":"Second IUATLD study on complications induced by intradermal BCG-vaccination","volume":"63","author":"Lotte","year":"1988","journal-title":"Bull Int Union Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.055_b0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/thx.54.9.762","article-title":"Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method","volume":"54","author":"Al Jarad","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2022.05.055_b0140","doi-asserted-by":"crossref","first-page":"a2052","DOI":"10.1136\/bmj.a2052","article-title":"Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: Randomised trial","volume":"337","author":"Hawkridge","year":"2008","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.vaccine.2022.05.055_b0145","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2018.03.009","article-title":"BCG vaccine: WHO position paper, February 2018\u2013recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.055_b0150","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006454-199405000-00012","article-title":"Simultaneous administration of childhood vaccines: An important public health policy that is safe and efficacious","volume":"13","author":"King","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.055_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s13312-015-0583-4","article-title":"Effect of simultaneous administration of oral polio vaccine on local reaction of BCG vaccine in term infants","volume":"52","author":"Faridi","year":"2015","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2022.05.055_b0160","first-page":"64","article-title":"BCG vaccination reaction in low birth weight infants","volume":"116","author":"Kaur","year":"2002","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2022.05.055_b0165","unstructured":"Statistics Bureau, Ministry of Internal Affairs and Communications. 2015 Population Census, https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&layout=datalist&toukei=00200521&tstat=000001080615&cycle=0&tclass1=000001089055&tclass2=000001089056 [accessed 17 January 2018]."},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.055_b0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"17","key":"10.1016\/j.vaccine.2022.05.055_b0175","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0264-410X(99)00403-X","article-title":"Case-control study of allergic reactions to Japanese encephalitis vaccine","volume":"18","author":"Plesner","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.055_b0180","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.055_b0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00130832-200112000-00003","article-title":"Mycobacterial diseases in primary immunodeficiencies","volume":"1","author":"Reichenbach","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2022.05.055_b0190","first-page":"809","article-title":"Severe adverse reactions after vaccination with Japanese BCG vaccine: A review","volume":"82","author":"Toida","year":"2007","journal-title":"Kekkaku"},{"key":"10.1016\/j.vaccine.2022.05.055_b0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0962-8479(96)90012-X","article-title":"Lymph node swelling due to Bacille Calmette-Guerin vaccination with multipuncture method","volume":"77","author":"Mori","year":"1996","journal-title":"Tuber Lung Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2022.05.055_b0200","doi-asserted-by":"crossref","first-page":"e12287","DOI":"10.1371\/journal.pone.0012287","article-title":"The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life","volume":"5","author":"Burl","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:04Z","timestamp":1759403944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22006727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22006727"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and incidence of vaccine adverse events after Bacille Calmette\u2013Gu\u00e9rin vaccination: A national surveillance study in Japan from 2013 to 2017","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}